Giammanco, Antonina
 Distribuzione geografica
Continente #
NA - Nord America 3.519
EU - Europa 2.034
AS - Asia 1.886
SA - Sud America 339
AF - Africa 65
OC - Oceania 7
Totale 7.850
Nazione #
US - Stati Uniti d'America 3.440
SG - Singapore 740
RU - Federazione Russa 697
IT - Italia 513
CN - Cina 384
BR - Brasile 278
VN - Vietnam 203
HK - Hong Kong 187
DE - Germania 152
PL - Polonia 139
FI - Finlandia 97
FR - Francia 95
GB - Regno Unito 92
BD - Bangladesh 88
IN - India 54
JP - Giappone 48
IE - Irlanda 45
CA - Canada 32
AT - Austria 29
NL - Olanda 29
MX - Messico 27
IQ - Iraq 26
TR - Turchia 25
AR - Argentina 22
BE - Belgio 22
SE - Svezia 21
ES - Italia 20
KR - Corea 20
RO - Romania 18
PK - Pakistan 17
ZA - Sudafrica 15
UA - Ucraina 14
EC - Ecuador 11
ID - Indonesia 11
KE - Kenya 11
GR - Grecia 10
SA - Arabia Saudita 10
IR - Iran 9
MA - Marocco 8
DZ - Algeria 7
MY - Malesia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
IL - Israele 6
LT - Lituania 6
PT - Portogallo 6
UY - Uruguay 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
EG - Egitto 5
HU - Ungheria 5
PE - Perù 5
TW - Taiwan 5
CI - Costa d'Avorio 4
CO - Colombia 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
VE - Venezuela 4
CY - Cipro 3
CZ - Repubblica Ceca 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
PH - Filippine 3
SN - Senegal 3
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MK - Macedonia 1
Totale 7.844
Città #
Ashburn 525
Singapore 489
Chandler 322
Fairfield 268
San Jose 220
Hong Kong 179
Houston 166
Seattle 150
Woodbridge 131
Moscow 123
Zgierz 115
New York 111
Wilmington 101
Cambridge 99
Palermo 89
Beijing 79
Council Bluffs 70
Los Angeles 66
Medford 64
Ho Chi Minh City 60
Ann Arbor 58
Altamura 54
Hanoi 53
Lauterbourg 52
Tokyo 46
Dallas 43
Dublin 42
Des Moines 41
Santa Clara 41
Princeton 40
Lawrence 38
London 33
Buffalo 29
Helsinki 27
Rome 27
Boardman 26
Milan 26
San Diego 25
São Paulo 24
Hefei 23
Nanjing 22
Brussels 20
Chennai 20
The Dalles 20
Frankfurt am Main 19
Memphis 19
Orem 19
Lappeenranta 18
Ludwigshafen am Rhein 18
Bremen 17
Venice 17
Haiphong 16
Chicago 15
Denver 15
Munich 15
Warsaw 15
Naples 14
Montreal 12
Atlanta 11
Jinan 11
Guangzhou 10
Johannesburg 10
Nairobi 10
Nuremberg 10
Shenyang 10
Baghdad 9
Biên Hòa 9
Da Nang 9
Hebei 9
Nanchang 9
Tianjin 9
Vienna 9
Amsterdam 8
Bologna 8
Boston 8
Brooklyn 8
Changsha 8
Dearborn 8
Falkenstein 8
Izmir 8
Paris 8
Phoenix 8
Belo Horizonte 7
Lahore 7
Mexico City 7
Rio de Janeiro 7
Stockholm 7
Tashkent 7
Cagliari 6
Erbil 6
Favara 6
Guarulhos 6
Manchester 6
Salt Lake City 6
Shenzhen 6
Tehran 6
Turku 6
Ankara 5
Baku 5
Campinas 5
Totale 4.812
Nome #
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 270
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 266
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 260
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 255
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 251
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 249
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 242
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 225
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 217
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 214
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 188
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome 187
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 183
Liver and statins: a critical appraisal of the evidence 180
Anti-PCSK9 treatment: Is ultra-low LDL always good? 178
Is echocardiography mandatory for patients with chronic kidney disease? 161
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 159
An unusual case of chronic diarrhea: a case report 153
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 152
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 144
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis 143
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias 140
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism 136
The pathophysiology of intestinal lipoprotein production 133
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 133
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases 130
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 129
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 128
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? 125
Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide 125
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 124
Valutazione in vivo dello stress ossidativo e dell'attivazione piastrinica nell'ipobetalipoproteinemia familiare: confronto con l'ipercolesterolemia familiare e l'iperalfalipoproteinemia familiare 123
FISIOPATOLOGIA DELLA SINTESI DELLE LIPOPROTEINE INTESTINALI 121
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 121
Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients 118
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 118
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 115
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 112
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME 110
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 108
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 106
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial 103
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 102
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization 101
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 98
Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia 88
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study 86
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia 82
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 77
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 73
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 67
Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development. 67
Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia 66
Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature 66
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 63
Clinical and Biochemical Characterization of Fabry Disease Associated GLA Gene Variants: Data From a Large Cohort of 469 Thousand Genotyped Subjects of the UK Biobank Database 62
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD 60
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program 51
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 48
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database 44
Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition 39
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 38
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 24
Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry 14
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry 12
Neutrophil-lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry 10
Echocardiographic Red Flags in Wild-Type Transthyretin Amyloidosis: Sex-Specific Gaps for Wall Thickness and Left Ventricular Mass 10
null 4
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 1
Totale 8.288
Categoria #
all - tutte 32.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022506 13 48 35 6 6 17 20 31 59 111 44 116
2022/2023903 74 174 31 116 67 138 37 79 110 10 33 34
2023/2024494 18 64 46 59 23 127 39 29 9 20 16 44
2024/20251.036 19 90 55 68 40 48 75 85 82 136 155 183
2025/20263.829 299 158 192 310 385 588 541 425 283 243 264 141
Totale 8.288